VolitionRx announces common stock offering, no amount given

VolitionRx Limited announced that it has commenced an underwritten public offering of shares of its common stock. Volition intends to use the net proceeds from the offering for research and continued product development, clinical studies, product commercialization, working capital and other general corporate purposes, including potential strategic acquisitions. Newbridge Securities Corporation is acting as the sole book-running manager of the offering.